CliffBio
small molecule

CLOBEX

CLOBETASOL PROPIONATE

Loss of exclusivity—loss of exclusivity
CompanyGalderma Laboratories, L.P. →See this company's full patent-cliff portfolio

Drug detail

Brand nameCLOBEX
Active ingredientCLOBETASOL PROPIONATE
Strength0.05%
Dosage formLOTION
RouteTOPICAL
ModalitySmall molecule
FDA approvalJuly 2003
Marketing statusRX

More from Galderma Laboratories, L.P.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CLOBEX patent cliff — loss of exclusivity — | CliffBio